KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Revenue: 2010-2024

Historic Revenue for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $1.0 billion.

  • Emergent BioSolutions' Revenue fell 21.34% to $231.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $788.9 million, marking a year-over-year decrease of 14.32%. This contributed to the annual value of $1.0 billion for FY2024, which is 0.54% down from last year.
  • As of FY2024, Emergent BioSolutions' Revenue stood at $1.0 billion, which was down 0.54% from $1.0 billion recorded in FY2023.
  • Over the past 5 years, Emergent BioSolutions' Revenue peaked at $1.8 billion during FY2021, and registered a low of $1.0 billion during FY2024.
  • Its 3-year average for Revenue is $1.1 billion, with a median of $1.0 billion in 2023.
  • Its Revenue has fluctuated over the past 5 years, first surged by 42.61% in 2020, then plummeted by 36.99% in 2022.
  • Over the past 5 years, Emergent BioSolutions' Revenue (Yearly) stood at $1.6 billion in 2020, then rose by 12.45% to $1.8 billion in 2021, then tumbled by 36.99% to $1.1 billion in 2022, then declined by 6.10% to $1.0 billion in 2023, then declined by 0.54% to $1.0 billion in 2024.